Cullen Frost Bankers Inc. Has $16.80 Million Stake in Humana Inc. (NYSE:HUM)

Cullen Frost Bankers Inc. trimmed its position in Humana Inc. (NYSE:HUM) by 2.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,701 shares of the insurance provider’s stock after selling 872 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Humana were worth $16,802,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Rakuten Securities Inc. acquired a new position in shares of Humana in the fourth quarter valued at $25,000. Gradient Investments LLC raised its stake in Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 40 shares in the last quarter. Cetera Trust Company N.A acquired a new position in Humana during the fourth quarter worth $28,000. Nvwm LLC raised its stake in Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after acquiring an additional 25 shares in the last quarter. Finally, Operose Advisors LLC acquired a new position in Humana during the third quarter worth $56,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Humana

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were bought at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the transaction, the director now directly owns 2,578 shares in the company, valued at approximately $946,358.02. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.29% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent analyst reports. StockNews.com lowered Humana from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 26th. UBS Group dropped their price objective on Humana from $334.00 to $326.00 and set a “neutral” rating for the company in a research note on Thursday, April 25th. Stephens dropped their price objective on Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a research note on Friday, January 26th. Truist Financial restated a “hold” rating and set a $550.00 target price on shares of Humana in a report on Friday, January 19th. Finally, Jefferies Financial Group decreased their target price on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $424.50.

Humana Trading Down 0.2 %

HUM traded down $0.49 during midday trading on Wednesday, reaching $324.14. 1,278,149 shares of the company were exchanged, compared to its average volume of 1,967,296. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. Humana Inc. has a one year low of $298.61 and a one year high of $541.21. The stock has a market capitalization of $39.06 billion, a P/E ratio of 20.18, a PEG ratio of 1.86 and a beta of 0.49. The stock’s 50-day simple moving average is $323.08 and its 200 day simple moving average is $385.94.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The company’s revenue was up 10.7% compared to the same quarter last year. During the same quarter last year, the business earned $9.38 earnings per share. As a group, analysts forecast that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.